Kidney cancer Clinical Trials in Springdale, AR
As of August 2026, 1 paid clinical trial is recruiting for Kidney cancer in Springdale, Arkansas. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Related specialties in Springdale
Filter results
1 clinical trial for Kidney cancer
·Clear filters·Top Research Study Locations in Springdale
Researchers run research studies in Springdale, AR at 12 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Highlands Oncology Group | Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Anatomic Stage II Breast Cancer AJCC v8 | 41 |
| Highlands Oncology Group, PA | Non-Small Cell Lung Cancer, Advanced or Metastatic Solid Tumors, Advanced/Metastatic Non-Small Cell Lung Cancer | 8 |
| Retina Partners of Northwest Arkansas, PLLC | Age-Related Macular Degeneration, Age-related Macular Degeneration (AMD), Choroidal Neovascularization | 3 |
| Highlands Oncology Group - Springdale | Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer, Multiple Myeloma | 3 |
| Adverum Clinical | Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD | 1 |
| Arkansas Children's Northwest | B-Cell ALL, B-Cell Acute Lymphoblastic Leukaemia, B-Cell Lymphoblastic Leukemia | 1 |
| Community Clinic | Diet, Healthy, Gestational Diabetes, Gestational Hypertension | 1 |
| Highlands Oncology Group-Research Department | Non Small Cell Lung Cancer | 1 |
| Local Institution - 0686 | Carcinoma, Non-Small-Cell Lung | 1 |
| Rouse Family Medical Clinic | Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | 1 |
| UAMS Institute for Community Health Innovation | Diabetes Mellitus, Type 2 | 1 |
| UAMS Springdale FMC | Maternal Health | 1 |
Active & Upcoming Studies in Springdale (2026)
Recruiting trials in Springdale grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (51 active studies)
- Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer · Phase 3 · SWOG Cancer Research Network
- A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma · Phase 3 · Janssen Research & Development, LLC
Eye & vision (4 active studies)
- A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002) · Phase 2, Phase 3 · EyeBiotech Ltd.
- Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS) · Phase 3 · Adverum Biotechnologies, Inc.
Diabetes & metabolic (3 active studies)
- Delivering HOPE (Helping Women Optimize Prenatal Equity) · University of Arkansas
- Family Model DSME in FBOs in the RMI · University of Arkansas
Cardiovascular (1 active study)
- Delivering HOPE (Helping Women Optimize Prenatal Equity) · University of Arkansas
Common conditions studied in Springdale
- Non-Small Cell Lung Cancer (5 active studies)
- Carcinoma, Non-Small-Cell Lung (4 active studies)
- Colorectal Neoplasms (3 active studies)
- Glioma (3 active studies)
- Advanced Non-Small Cell Lung Cancer (2 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (2 active studies)
Leading research sponsors in Springdale
- Pfizer
- National Cancer Institute (NCI)
- SWOG Cancer Research Network
- AstraZeneca
- Merck Sharp & Dohme LLC
Frequently asked questions
How many paid clinical trials are currently recruiting in Springdale?
There are approximately 66 recruiting clinical trials in Springdale, Arkansas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Springdale pay participants?
Most recruiting trials in Springdale compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Springdale?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Springdale?
The most common conditions under active study in Springdale include Non-Small Cell Lung Cancer (5), Carcinoma, Non-Small-Cell Lung (4), Colorectal Neoplasms (3), Glioma (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Springdale?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Springdale on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Springdale?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Springdale?
Recruiting research sites in Springdale include Highlands Oncology Group, Highlands Oncology Group, PA, Retina Partners of Northwest Arkansas, PLLC, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Springdale right now?
The largest active categories in Springdale are Cancer & tumors (51), Eye & vision (4), Diabetes & metabolic (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.